CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.23675
+0.00695 (3.02%)
At close: Nov 9, 2026
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $347.91 million as of November 9, 2026. It is the 16,950th most valuable company in the world and the 3,035th biggest in the United States. Its market cap has increased by 12.50% in one year.
Market Cap
347.91M
Enterprise Value
358.82M
Revenue
n/a
Global Rank
Country Rank
#3,035 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 347.91M, an increase of 6,182.71%. That is a compound annual growth rate of 21.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 347.91M | -2.17% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 1.19B |
| Northwest Biotherapeutics | 297.06M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 209.33M |
| BetterLife Pharma | 92.36M |
| Vaxart | 89.98M |
| ProText Mobility | 66.81M |
| Nuo Therapeutics | 51.82M |